Mexico, Nov. 5 (Notimex).- Andrea Sánchez Navarro, of the Biomedical Research Institute (IIBO, for its acronym in Spanish) of the National Autonomous University of Mexico (UNAM, for its acronym in Spanish1), is working on the development of a model that allows the progression of chronic kidney disease to be detected in an early way.
The young student was awarded the National Youth Award 2018, in the category of Science and Technology.
The research is about a protein, of which they already have the patent, which allows to find early the symptoms of chronic kidney disease: "this molecule would work as a diagnostic method to evaluate in a timely manner the development of the disease, which in clinics it is detected late, when the function of the kidneys is already deteriorated," explained the doctoral student.
The 24-year-old is originally from La Piedad, Michoacán and currently holds a doctorate in biomedical sciences from the IIBO, at its peripheral headquarters, the National Institute of Medical Sciences and Nutrition "Salvador Zubirán", where she carries out this research simultaneously with other projects and has the advice of scientist Norma Bobadilla Sandoval.
Currently, tests are performed on patient samples and it has been found that the molecule is less invasive, it is helping to detect nephrogenic fibrosis, avoids renal biopsy and seeks, with its early and timely detection, to achieve a better outcome of the treatments.
According to UNAM Global, the researcher feels happy and honored to receive this award because since she was little she became interested in the chemical-biological area. She always loved science, grew up in the laboratory with his mother, chemist-biologist by profession, doing experiments, "curiosity is the pillar of researchers."
She feels like a responsibility to encourage other young people to do what they like and surround themselves with the right people, "knowing Norma Bobadilla was a success in my life because she has driven me and helped me to exploit my potential, to have her as a model is her example to follow, is one of the pillars of my academic training.
Its goal is that this molecule can reach health systems in the short term, "although investment and other factors that combine to achieve it are required".